Products
16870 Results
| Quick actions | ISIN | UL | Product | Direction | SL | Ref. | Bid | Spread | Ask | Ratio | % day | % week | % month | Issue date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nike Constant Leverage with ISIN code: CH1119067994 | Nike | Constant Leverage | Short | ― | 75.713 | 0.48 | 0.030 | 0.51 | 1 | -5.88% | -26.15% | -70.37% | 12 May. 2022 | |
| Nike Constant Leverage with ISIN code: CH1345999507 | Nike | Constant Leverage | Short | ― | 75.713 | 0.19 | 0.030 | 0.22 | 1 | -13.64% | -40.63% | -93.71% | 18 Apr. 2024 | |
| Nokia Constant Leverage with ISIN code: CH1235293177 | Nokia | Constant Leverage | Long | ― | 4.378 | 0.15 | 0.010 | 0.16 | 1 | -6.25% | -6.25% | -40.00% | 30 Nov. 2022 | |
| Nokia Constant Leverage with ISIN code: CH1119067226 | Nokia | Constant Leverage | Long | ― | 4.378 | 0.89 | 0.010 | 0.9 | 1 | -1.11% | -1.11% | -29.92% | 6 May. 2022 | |
| Nokia Constant Leverage with ISIN code: CH1235293169 | Nokia | Constant Leverage | Short | ― | 4.378 | 1.08 | 0.010 | 1.09 | 1 | -0.92% | 0.00% | 30.12% | 30 Nov. 2022 | |
| Novartis Constant Leverage with ISIN code: CH1423416671 | Novartis | Constant Leverage | Long | ― | 98.12 | 18.13 | 0.370 | 18.5 | 1 | -2.00% | 14.38% | -6.59% | 12 May. 2025 | |
| Novartis Constant Leverage with ISIN code: CH1276587271 | Novartis | Constant Leverage | Long | ― | 98.12 | 9.33 | 0.080 | 9.41 | 1 | -0.85% | 5.78% | -0.11% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1276587305 | Novartis | Constant Leverage | Long | ― | 98.12 | 0.95 | 0.030 | 0.98 | 1 | -3.06% | 10.47% | -5.00% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1276587289 | Novartis | Constant Leverage | Long | ― | 98.12 | 6.03 | 0.070 | 6.1 | 1 | -1.15% | 8.26% | -0.99% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1276587297 | Novartis | Constant Leverage | Long | ― | 98.12 | 2.87 | 0.050 | 2.92 | 1 | -1.71% | 10.38% | -2.38% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1276587255 | Novartis | Constant Leverage | Short | ― | 98.12 | 0.94 | 0.030 | 0.97 | 1 | -3.09% | -14.55% | -10.48% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1276587263 | Novartis | Constant Leverage | Short | ― | 98.12 | 2.6 | 0.030 | 2.63 | 1 | -1.14% | -8.45% | -5.45% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1423416655 | Novartis | Constant Leverage | Short | ― | 98.12 | 2.99 | 0.080 | 3.07 | 1 | -2.61% | -26.72% | -21.73% | 12 May. 2025 | |
| Novartis Constant Leverage with ISIN code: CH1276587248 | Novartis | Constant Leverage | Short | ― | 98.12 | 0.27 | 0.030 | 0.3 | 1 | -10.00% | -25.00% | -20.59% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1423416663 | Novartis | Constant Leverage | Short | ― | 98.12 | 3.8 | 0.090 | 3.89 | 1 | -2.31% | -22.13% | -17.21% | 12 May. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1346000271 | Novo Nordisk | Constant Leverage | Long | ― | 451.072 | 0.056 | 0.003 | 0.059 | 1 | -5.08% | 1.82% | -37.08% | 9 Jul. 2024 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1276587339 | Novo Nordisk | Constant Leverage | Long | ― | 451.072 | 0.14 | 0.020 | 0.16 | 1 | -12.50% | -6.67% | -39.13% | 13 Oct. 2023 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1290993299 | Novo Nordisk | Constant Leverage | Long | ― | 451.072 | 0.001 | ― | ― | 1 | 0.00% | 0.00% | 0.00% | 11 Mar. 2024 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1290993042 | Novo Nordisk | Constant Leverage | Long | ― | 451.072 | 0.001 | ― | ― | 1 | 0.00% | 0.00% | 0.00% | 23 Feb. 2024 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1396327897 | Novo Nordisk | Constant Leverage | Long | ― | 451.072 | 0.052 | 0.003 | 0.055 | 1 | -5.45% | 20.93% | -74.00% | 29 Jan. 2025 |
The underlying prices shown are not real-time prices, i.e. they are delayed due to legal requirements of the data provider. As a consequence, the price of the product on a specific underlying may substantially differ from the price of the product that you would expect on the basis of the underlying price displayed.